Skip to main content

You must have JavaScript enabled in order to access this part of the site. Please enable JavaScript and then reload this page in order to continue.

May 2026 TMPPM Update for Colony Stimulating Factors

Last updated on

On May 1, 2026, the Texas Medicaid & Healthcare Partnership (TMHP) will update the “Colony Stimulating Factors (Filgrastim and Pegfilgrastim)” section of the Texas Medicaid Provider Procedures Manual (TMPPM), Outpatient Drug Services Handbook to add filgrastim-txid (Nypozi) (procedure code Q5148), which is a filgrastim biosimilar.

For more information, call the TMHP Contact Center at 800-925-9126.

Note: Texas Medicaid managed care organizations (MCOs) must provide all medically necessary, Medicaid-covered services to Medicaid members who are enrolled in their MCO. Administrative procedures, such as prior authorization, precertification, referrals, and claims and encounter data filing, may differ from traditional Medicaid (fee-for-service) and from MCO to MCO. Providers should contact the member’s specific MCO for details.